Delcath Systems to Present at Upcoming Virtual Investor Conferences
11 February 2022 - 8:30AM
Delcath Systems, Inc. (Nasdaq: DCTH), an interventional oncology
company focused on the treatment of primary and metastatic cancers
of the liver, announced today that management will participate at
these upcoming virtual investor conferences:
- The BTIG Virtual MedTech, Digital Health, Life Science &
Diagnostic Tools Conference
- February 17, 2022, at 11:00 AM ET
- This is a BTIG hosted event and will not be webcast. Please
contact your BTIG representative for further information.
- 2022 SVB Leerink Global Healthcare Conference
- February 18, 2022, at 9:20 AM ET
- Webcast link:
https://wsw.com/webcast/svbleerink67/dcth/2630150
To learn more or to schedule a one-on-one meeting with
management, please contact your conference representative or
james@haydenir.com.
About Delcath Systems, Inc.
Delcath Systems, Inc. is an interventional oncology company
focused on the treatment of primary and metastatic liver cancers.
The company’s proprietary percutaneous hepatic perfusion (PHP)
system is designed to administer high-dose chemotherapy to the
liver while controlling systemic exposure and associated side
effects. In the United States, the PHP system is being developed
under the tradename HEPZATO KIT (melphalan hydrochloride for
injection/hepatic delivery system), or HEPZATO, for the treatment
of metastatic ocular melanoma (mOM), also known as metastatic uveal
melanoma (mUM) and is considered a combination drug and device
product regulated by the United States Food and Drug Administration
(FDA).
In Europe, the PHP system is regulated as a Class IIb medical
device and is approved for sale under the trade name CHEMOSAT
Hepatic Delivery System for Melphalan, or CHEMOSAT, where it has
been used at major medical centers to treat a wide range of cancers
of the liver.
Contact:
Delcath Investor Relations
Email: investorrelations@delcath.com
Hayden IR
James
Carbonara(646)-755-7412james@haydenir.com
Delcath Systems (NASDAQ:DCTH)
Historical Stock Chart
From Jun 2024 to Jul 2024
Delcath Systems (NASDAQ:DCTH)
Historical Stock Chart
From Jul 2023 to Jul 2024